Burning Rock Biotech Limited ( BNR) - Key Metrics
BNR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | $102.61 | -$16.61 | -$27.86 | -$27.86 |
| 2025Q4 | $120.57 | -$14.69 | $21.99 | $16.98 |
| 2025Q3 | $122.23 | -$15.56 | $15.22 | $15.22 |
| 2025Q2 | $137.96 | -$9.01 | -$41.18 | -$41.18 |
| 2025Q1 | $123.66 | -$12.54 | -$21.86 | -$21.86 |
BNR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | 0% | -1.64 |
| 2025Q4 | 0% | -2.40 |
| 2025Q3 | 0% | -0.99 |
| 2025Q2 | 0% | -0.63 |
| 2025Q1 | 0% | -0.65 |
BNR
Price: $11.99
52 week price:
Earnings Per Share: -0.83 USD
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Country: China
Volume: 139800
Market Capitalization: 126.5 million